Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Breast Cancer
•
Radiation Oncology
Is there any reason to stop mesalamine in a patient with UC undergoing breast/regional nodal radiation?
Answer from: Radiation Oncologist at Academic Institution
I have run into this situation a few times and have not stopped mesalamine during breast radiation. Have not noticed any issues.
Sign in or Register to read more
11392
Related Questions
What dose constraints do you when treating a patient with bilateral breast cancers with RNI?
Is it reasonable to offer APBI in an obese patients with large breasts and N1mi disease?
Would you ever considering de-escalating therapy in any way for women with inflammatory breast cancer who had a complete pathologic response after surgery?
Why do we tend to boost grade 3 DCIS, but not grade 1 invasive disease?
Do you offer APBI to patients who do not have surgical clips but a visible seroma?
With the more recent validation studies, have you integrated the use of DCISion RT into your practice?
Are there any accruing trials in the U.S. evaluating selective use of radiation after mastectomy in early stage breast cancer?
How would you approach a cT4 cN2 (22 cm in size) TNBC that shrank to 9 cm with KN-522 regimen but remains inoperable at the end of treatment?
How do you approach breast RT in a patient with a recent history of ipsilateral thoracic irradiation?
Are there increased risks of radiation therapy in a patient with polymorphous light eruption?